Technical University of Munich
tum.deTotal trials
311
Active
47
Phase 3
13
Total enrollment
429,658
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Comirnaty Injectable Product | — | — | — | — | — | 1 | |
| Sodium Chloride 0.9% Inj | — | — | — | — | — | 1 | |
| Fasudil hydrochloride | — | — | — | — | — | 1 | |
| Experimental: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] | — | — | — | — | — | 1 | |
| RAVICTI 1.1 g/ml | — | — | — | — | — | 1 | |
| Propofol | — | — | — | — | 4 |
Next readouts
- 2024-09-10
- 2025-09-01
- 2026-03-30
- 2026-09-30
- 2027-10
Top conditions
- Obesity6
- Breast Cancer6
- Schizophrenia6
- Colon Adenoma5
- Anesthesia5
- Critical Illness5
- Critical Care5
- Healthy4
Frequently asked questions about Technical University of Munich
- How many clinical trials does Technical University of Munich have on ClinicalTrials.gov?
- Technical University of Munich is listed as the lead sponsor on 311 clinical trials in ClinicalTrials.gov, 47 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Technical University of Munich's trials are in Phase 3?
- 13 of Technical University of Munich's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Technical University of Munich focus on?
- Technical University of Munich's most-studied conditions on ClinicalTrials.gov are Obesity, Breast Cancer, Schizophrenia, Colon Adenoma, Anesthesia.
- When are Technical University of Munich's next clinical trial readouts?
- Technical University of Munich has 5 upcoming primary-completion readouts tracked here; the soonest is “EEG-fMRI Experiments During Anesthesia Induction With Propofol”, expected around 2024-09-10.